FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Davis

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Siddharth Bethi; Abhijit Dasgupta; John C Davis; Lianne S Gensler; Thomas J Learch; John D Reveille; Michael H Weisman; Michael M Ward
Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?
Michael M Ward; John C Davis; Lianne S Gensler; Thomas J Learch; John D Reveille; Michael H Weisman
Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.
Gunnar Tomasson; Michael Walsh; Steven R Ytterberg; Paul A Monach; Philip Seo; Ulrich Specks; Robert Spiera; E William St Clair; John H Stone; Maarten Boers; Simon Carette; David Cuthbertson; John C Davis; Gary S Hoffman; Nader A Khalidi; Carol A Langford; Michael P LaValley; Carol A McAlear; W Joseph McCune; Peter A Merkel
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Siddharth Bethi; Abhijit Dasgupta; John C Davis; Lianne S Gensler; Thomas J Learch; John D Reveille; Michael H Weisman; Michael M Ward
Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?
Arthritis care & research 2013;65(4):607-14.
2013: Michael M Ward; John C Davis; Lianne S Gensler; Thomas J Learch; John D Reveille; Michael H Weisman
Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.
Arthritis care & research 2013;65(2):257-65.
2012: Gunnar Tomasson; Michael Walsh; Steven R Ytterberg; Paul A Monach; Philip Seo; Ulrich Specks; Robert Spiera; E William St Clair; John H Stone; Maarten Boers; Simon Carette; David Cuthbertson; John C Davis; Gary S Hoffman; Nader A Khalidi; Carol A Langford; Michael P LaValley; Carol A McAlear; W Joseph McCune; Peter A Merkel
Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's).
Arthritis care & research 2012;64(2):273-9.
2009: Michael M Ward; Matthew R Hendrey; James D Malley; Thomas J Learch; John C Davis; John D Reveille; Michael H Weisman
Clinical and immunogenetic prognostic factors for radiographic severity in ankylosing spondylitis.
Arthritis and rheumatism 2009;61(7):859-66.
2009: Javier D Finkielman; Peter A Merkel; D Schroeder; Gary S Hoffman; Robert Spiera; E William St Clair; John C Davis; W Joseph McCune; A Lears; Steven R Ytterberg; Amber M Hummel; Margaret A Viss; Tobias Peikert; John H Stone; Ulrich Specks
Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis.
Clinical and experimental rheumatology 2009;27(1 Suppl 52):S45-52.
2008: John C Davis; Philip J Mease
Insights into the pathology and treatment of spondyloarthritis: from the bench to the clinic.
Seminars in arthritis and rheumatism 2008;38(2):83-100.
2008: Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Occupational physical activities and long-term functional and radiographic outcomes in patients with ankylosing spondylitis.
Arthritis and rheumatism 2008;59(6):822-32.
2008: Alfred Mahr; Tuhina Neogi; Michael P LaValley; John C Davis; Gary S Hoffman; W Joseph McCune; Ulrich Specks; Robert Spiera; E William St Clair; John H Stone; Peter A Merkel
Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis.
Arthritis and rheumatism 2008;59(6):884-91.
2008: Peter K Wung; Troy Anderson; Kevin R Fontaine; Gary S Hoffman; Ulrich Specks; Peter A Merkel; Robert Spiera; John C Davis; E William St Clair; W Joseph McCune; John H Stone
Effects of glucocorticoids on weight change during the treatment of Wegener's granulomatosis.
Arthritis and rheumatism 2008;59(5):746-53.
2008: Michael M Ward; John D Reveille; Thomas J Learch; John C Davis; Michael H Weisman
Impact of ankylosing spondylitis on work and family life: comparisons with the US population.
Arthritis and rheumatism 2008;59(4):497-503.
2008: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; Daniel O Clegg; Alan J Kivitz; R M Fleischmann; Robert D Inman; L Ni; S-L Lin; Wayne Tsuji
Efficacy and safety of up to 192 weeks of etanercept therapy in patients with ankylosing spondylitis.
Annals of the rheumatic diseases 2008;67(3):346-52.
2007: Jodi K Sebastian; Barbara Voetsch; John H Stone; Zurina Romay-Penabad; Grace H Lo; Nancy B Allen; John C Davis; Gary S Hoffman; W Joseph McCune; E William St Clair; Ulrich Specks; Robert Spiera; Joseph Loscalzo; Silvia S Pierangeli; Peter A Merkel
The frequency of anticardiolipin antibodies and genetic mutations associated with hypercoagulability among patients with Wegener's granulomatosis with and without history of a thrombotic event.
The Journal of rheumatology 2007;34(12):2446-50.
2007: Javier D Finkielman; Peter A Merkel; Darrell Schroeder; Gary S Hoffman; Robert Spiera; E William St Clair; John C Davis; W Joseph McCune; Andrea K Lears; Steven R Ytterberg; Amber M Hummel; Margaret A Viss; Tobias Peikert; John H Stone; Ulrich Specks
Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.
Annals of internal medicine 2007;147(9):611-9.
2007: John C Davis; Dennis Revicki; Désirée van der Heijde; Anne M Rentz; Robert L Wong; Hartmut Kupper; Michelle P Luo
Health-related quality of life outcomes in patients with active ankylosing spondylitis treated with adalimumab: results from a randomized controlled study.
Arthritis and rheumatism 2007;57(6):1050-7.
2007: Javier D Finkielman; Augustine S Lee; Amber M Hummel; Margaret A Viss; Gregory L Jacob; Henry A Homburger; Tobias Peikert; Gary S Hoffman; Peter A Merkel; Robert Spiera; E William St Clair; John C Davis; W Joseph McCune; Andrea K Tibbs; Steven R Ytterberg; John H Stone; Ulrich Specks
ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.
The American journal of medicine 2007;120(7):643.e9-14.
2007: Jodi K Sebastian; Alfred Mahr; Sohail S Ahmed; John H Stone; Zurina Romay-Penabad; John C Davis; Gary S Hoffman; W Joseph McCune; E William St Clair; Ulrich Specks; Robert Spiera; Silvia S Pierangeli; Peter A Merkel
Antiendothelial cell antibodies in patients with Wegener's granulomatosis: prevalence and correlation with disease activity and manifestations.
The Journal of rheumatology 2007;34(5):1027-31.
2006: Miriam A Bredella; Lynne S Steinbach; Stephanie Morgan; Michael Ward; John C Davis
MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis.
AJR. American journal of roentgenology 2006;187(6):1420-6.
2006: John C Davis; Maxime Dougados; Jurgen Braun; J Sieper; Désirée van der Heijde; S van der Linden
Definition of disease duration in ankylosing spondylitis: reassessing the concept.
Annals of the rheumatic diseases 2006;65(11):1518-20.
2006: Robert D Inman; Daniel O Clegg; John C Davis; James B Whitmore; Alan Solinger
Etanercept in adult patients with early onset ankylosing spondylitis.
The Journal of rheumatology 2006;33(8):1634-6.
2006: Désirée van der Heijde; Alan J Kivitz; Michael H Schiff; Joachim Sieper; B A C Dijkmans; Jürgen Braun; Maxime Dougados; John D Reveille; Robert L Wong; Hartmut Kupper; John C Davis
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2006;54(7):2136-46.
2006: Michael M Ward; Jane Bruckel; Robert Colbert; Atul Doedhar; Christopher Emerson; Harry K Genant; Dafna D Gladman; Robert Inman; John D Reveille; Christy Sandborg; Michael H Weisman; John C Davis
Summary of the 2005 annual research and education meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN).
The Journal of rheumatology 2006;33(5):978-82.
2006: John H Stone; Janet T Holbrook; Matthew A Marriott; Andrea K Tibbs; Lourdes P Sejismundo; Yuan-I Min; Ulrich Specks; Peter A Merkel; Robert Spiera; John C Davis; E William St Clair; W Joseph McCune; Steven R Ytterberg; Nancy B Allen; Gary S Hoffman
Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial.
Arthritis and rheumatism 2006;54(5):1608-18.
2006: Cailin Henderson; John C Davis
Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis.
Nature clinical practice. Rheumatology 2006;2(4):211-8.
2005: Peter K Wung; Janet T Holbrook; Gary S Hoffman; Andrea K Tibbs; Ulrich Specks; Yuan-I Min; Peter A Merkel; Robert Spiera; John C Davis; E William St Clair; Joseph M McCune; Steven R Ytterberg; Nancy B Allen; John H Stone
Herpes zoster in immunocompromised patients: incidence, timing, and risk factors.
The American journal of medicine 2005;118(12):1416.
2005: Marc A Dall'Era; Pina M Cardarelli; Benjamin T Preston; A Witte; John C Davis
Type I interferon correlates with serological and clinical manifestations of SLE.
Annals of the rheumatic diseases 2005;64(12):1692-7.
2005: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; John J Cush; D Clegg; Robert D Inman; Alan J Kivitz; L Zhou; A Solinger; Wayne Tsuji
Sustained durability and tolerability of etanercept in ankylosing spondylitis for 96 weeks.
Annals of the rheumatic diseases 2005;64(11):1557-62.
2005: Michael M Ward; Michael H Weisman; John C Davis; John D Reveille
Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.
Arthritis and rheumatism 2005;53(5):710-7.
2005: John C Davis; Désirée van der Heijde; Maxime Dougados; Jurgen Braun; John J Cush; Daniel O Clegg; Robert D Inman; Todd de Vries; Wayne Tsuji
Baseline factors that influence ASAS 20 response in patients with ankylosing spondylitis treated with etanercept.
The Journal of rheumatology 2005;32(9):1751-4.
2005: B Gescuk; A J Wu; John P Whitcher; TE Daniels; S Lund; Kenneth H Fye; John C Davis
Lamivudine is not effective in primary Sjögren's syndrome.
Annals of the rheumatic diseases 2005;64(9):1326-30.
2005: John C Davis; Désirée van der Heijde; Maxime Dougados; J Michael Woolley
Reductions in health-related quality of life in patients with ankylosing spondylitis and improvements with etanercept therapy.
Arthritis and rheumatism 2005;53(4):494-501.
2005: Philip Seo; Yuan-I Min; Janet T Holbrook; Gary S Hoffman; Peter A Merkel; Robert Spiera; John C Davis; Steven R Ytterberg; E William St Clair; W Joseph McCune; Ulrich Specks; Nancy B Allen; Raashid Luqmani; John H Stone
Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Arthritis and rheumatism 2005;52(7):2168-78.
2005: Peter A Merkel; Grace H Lo; Janet T Holbrook; Andrea K Tibbs; Nancy B Allen; John C Davis; Gary S Hoffman; W Joseph McCune; E William St Clair; Ulrich Specks; Robert Spiera; Michelle Petri; John H Stone
Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study.
Annals of internal medicine 2005;142(8):620-6.
2005: John H Stone; Vinodh N Rajapakse; Gary S Hoffman; Ulrich Specks; Peter A Merkel; Robert Spiera; John C Davis; E William St Clair; Joseph M McCune; Sally Ross; Ben A Hitt; Timothy D Veenstra; Thomas P Conrads; Lance A Liotta; Emanuel F Petricoin
A serum proteomic approach to gauging the state of remission in Wegener's granulomatosis.
Arthritis and rheumatism 2005;52(3):902-10.
2005: John C Davis
Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis.
Seminars in arthritis and rheumatism 2005;34(4):668-77.
2004: Astrid J B Wanders; Jennifer D Gorman; John C Davis; Robert B M Landewe; Désirée van der Heijde
Responsiveness and discriminative capacity of the assessments in ankylosing spondylitis disease-controlling antirheumatic therapy core set and other outcome measures in a trial of etanercept in ankylosing spondylitis.
Arthritis and rheumatism 2004;51(1):1-8.
2003: Maria Dall'Era; John C Davis
Systemic lupus erythematosus. How to manage, when to refer.
Postgraduate medicine 2003;114(5):31-7, 40.
2003: John C Davis; Désirée van der Heijde; Jurgen Braun; Maxime Dougados; John J Cush; Daniel O Clegg; Alan J Kivitz; Roy Fleischmann; Robert Inman; Wayne Tsuji
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.
Arthritis and rheumatism 2003;48(11):3230-6.
2003: Kazuki Takada; Carol L Danning; Takashi Kuroiwa; Ryan Schlimgen; Ioannis Tassiulas; John C Davis; Cheryl H Yarboro; Thomas A Fleisher; Dimitrios T Boumpas; Gabor G Illei
Lymphocyte depletion with fludarabine in patients with psoriatic arthritis: clinical and immunological effects.
Annals of the rheumatic diseases 2003;62(11):1112-5.
2003: John C Davis; Feng Huang; Walter P Maksymowych
New therapies for ankylosing spondylitis: etanercept, thalidomide, and pamidronate.
Rheumatic diseases clinics of North America 2003;29(3):481-94, viii.
2002: Kenneth C Kalunian; John C Davis; Joan T Merrill; Mark C Totoritis; David Wofsy
Treatment of systemic lupus erythematosus by inhibition of T cell costimulation with anti-CD154: a randomized, double-blind, placebo-controlled trial.
Arthritis and rheumatism 2002;46(12):3251-8.
2002: John C Davis
The role of etanercept in ankylosing spondylitis.
Clinical and experimental rheumatology 2002;20(6 Suppl 28):S111-5.
2002: Bryan D Gescuk; John C Davis
Novel therapeutic agents for systemic lupus erythematosus.
Current opinion in rheumatology 2002;14(5):515-21.
2002: Jennifer D Gorman; Kenneth E Sack; John C Davis
Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
The New England journal of medicine 2002;346(18):1349-56.
2001: John H Stone; Gary S Hoffman; Peter A Merkel; Yuan-I Min; Misty L Uhlfelder; David B Hellmann; Ulrich Specks; Nancy B Allen; John C Davis; Robert Spiera; L H Calabrese; Fredrick M Wigley; N Maiden; R M Valente; John L Niles; Kenneth H Fye; W Joseph McCune; E William St Clair; Raashid Luqmani
A disease-specific activity index for Wegener's granulomatosis: modification of the Birmingham Vasculitis Activity Score. International Network for the Study of the Systemic Vasculitides (INSSYS).
Arthritis and rheumatism 2001;44(4):912-20.
2001: John C Davis; Mark C Totoritis; J Rosenberg; T A Sklenar; David Wofsy
Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus.
The Journal of rheumatology 2001;28(1):95-101.
2000: Jennifer D Gorman; Carol L Danning; H R Schumacher; JOHN KLIPPEL; John C Davis
Multicentric reticulohistiocytosis: case report with immunohistochemical analysis and literature review.
Arthritis and rheumatism 2000;43(4):930-8.
1999: A L McCoy; michael bubb; Paul H Plotz; John C Davis
Inclusion body myositis long after dermatomyositis: a report of two cases.
Clinical and experimental rheumatology 1999;17(2):235-9.
1999: John C Davis; S Manzi; Cheryl H Yarboro; JE Rairie; Iain B McInnes; D Averthelyi; D Sinicropi; V G Hale; James E Balow; HA Austin; Dimitrios T Boumpas; JOHN KLIPPEL
Recombinant human Dnase I (rhDNase) in patients with lupus nephritis.
Lupus 1999;8(1):68-76.
1998: John C Davis; B J Fessler; Ioannis Tassiulas; Iain B McInnes; Cheryl H Yarboro; Stanley R Pillemer; Ronald L Wilder; Thomas A Fleisher; JOHN KLIPPEL; Dimitrios T Boumpas
High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
The Journal of rheumatology 1998;25(9):1694-704.
1998: Ioannis Tassiulas; Ivona Aksentijevich; J E Salmon; Y Kim; Cheryl H Yarboro; EM Vaughan; John C Davis; D L Scott; HA Austin; JOHN KLIPPEL; James E Balow; Mark Gourley; Dimitrios T Boumpas
Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients.
Clinical nephrology 1998;50(1):8-13.
1998: John C Davis; HA Austin; Dimitrios T Boumpas; Thomas A Fleisher; Cheryl H Yarboro; A Larson; James E Balow; JOHN KLIPPEL; D Scott
A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis.
Arthritis and rheumatism 1998;41(2):335-43.
1996: John C Davis; Ioannis Tassiulas; Dimitrios T Boumpas
Lupus nephritis.
Current opinion in rheumatology 1996;8(5):415-23.